Results 181 to 190 of about 265,755 (306)

Left atrial function in uraemic patients: Four‐dimensional automatic left atrial quantitative technology study

ESC Heart Failure, Volume 12, Issue 2, Page 1316-1325, April 2025.
Abstract Objective This study aimed to evaluate the utility of left atrial volume and function in uraemic patients using four‐dimensional automatic left atrial quantification (4D auto LAQ) technology. Methods Thirty‐four undialysed uraemic patients (U‐ND group), 60 dialysed uraemic patients (U‐D group), and 32 healthy volunteers (N group) were enrolled
Bing Li, Meihua Chen, Xuning Huang
wiley   +1 more source

Strategies for preventing arrhythmic sudden death in adult congenital heart disease. [PDF]

Eur Heart J Suppl
Sarubbi B, Waldmann V, Ciriello GD, Wong T, Cano Ó.   +4 more
europepmc   +1 more source

Noninvasive cardiac radiation for ablation of ventricular tachycardia [PDF]

, 2017
Cooper, Daniel, Cuculich, Phillip S, Faddis, Mitchell, Gleva, Marye, Hallahan, Dennis, Kashani, Rojano, Lang, Adam, Mutic, Sasa, Noheria, Amit, Robinson, Clifford G, Rudy, Yoram, Schill, Matthew R, Smith, Timothy W   +12 more
core   +2 more sources

Exercise limitations in amyloid cardiomyopathy assessed by cardiopulmonary exercise testing—A multicentre study

ESC Heart Failure, Volume 12, Issue 2, Page 1326-1335, April 2025.
Abstract Aims Amyloid cardiomyopathy is caused by the deposition of light chain (AL) or transthyretin amyloid (ATTR) fibrils, that leads to a restrictive cardiomyopathy, often resulting in heart failure (HF) with preserved or reduced ejection fraction.
Robin Willixhofer, Mauro Contini, Michele Emdin, Damiano Magrì, Alice Bonomi, Elisabetta Salvioni, Fabrizio Celeste, Alberico Del Torto, Claudio Passino, Christophe D.J. Capelle, Chiara Arzilli, Emiliano Fiori, Nicolò Capra, Christina Kronberger, Nikita Ermolaev, Andreas Kammerlander, Beatrice Musumeci, Giuseppe Vergaro, Vincenzo Castiglione, René Rettl, Giacomo Tini, Andrea Baggiano, Iacopo Fabiani, Susanna Sciomer, Roza Badr Eslam, Piergiuseppe Agostoni   +25 more
wiley   +1 more source

Pulsed-field ablation in a patient with ventricular arrhythmia storm receiving mechanical circulatory support

HeartRhythm Case Reports
Alan Hanley, MB, MSc, Saumya Das, MD, PhD, Tri Nguyen, CEPS, RT(R), Ioannis Mastoris, MD, Eriberto Michel, MD, James R. Stone, MD, PhD, Jerome Crowley, MD, MPH, Greg Michaud, MD   +7 more
doaj   +1 more source

A Heart Under Stress: Anaesthetic Strategy for a Pregnant Patient With Long QT Syndrome. [PDF]

Cureus
Nascimento MJ, Silva M, Bernardino A, Carvalhas J.   +3 more
europepmc   +1 more source

Cardiogenic shock mortality according to Aetiology in a Mediterranean cohort: Results from the Shock‐CAT study

ESC Heart Failure, Volume 12, Issue 2, Page 1336-1345, April 2025.
Abstract Aims Mortality in cardiogenic shock (CS) remains elevated, with the potential for CS causes to impact prognosis and risk stratification. The aim was to investigate in‐hospital prognosis and mortality in CS patients according to aetiology. We also assessed the prognostic accuracy of CardShock and IABP‐SHOCK II scores.
Cosme García‐García, Teresa López‐Sobrino, Esther Sanz‐Girgas, Maria R. Cueto, Jaime Aboal, Pablo Pastor, Irene Buera, Alessandro Sionis, Rut Andrea, Judit Rodríguez‐López, Jose Carlos Sánchez‐Salado, Carlos Tomas, Jordi Bañeras, Albert Ariza, Josep Lupón, Antoni Bayés‐Genís, Ferran Rueda, Grup de Treball de Cures Agudes Cardiològiques Societat Catalana de Cardiologia   +17 more
wiley   +1 more source

An Exploratory Cross-Sectional Study on Cardiac Rhythm Disorders in Women Working in IT Sector and Non-IT Sector Establishments in Hyderabad Using Continuous Ambulatory Wireless Cardiac Monitoring. [PDF]

Cureus
Bala S, Bandaru RK, Surapaneni SRA, Abaka HR, Darivemula SB, Tondare D, Mirza M.   +6 more
europepmc   +1 more source

Heart failure in two male patients with late‐onset Fabry mutation (IVS4 + 919G > A)

ESC Heart Failure, Volume 12, Issue 2, Page 1508-1513, April 2025.
Xufei Yang, Chunlan Deng, Xiaogang Guo, Hui Yan   +3 more
wiley   +1 more source

Dapagliflozin alleviates high‐fat‐induced obesity cardiomyopathy by inhibiting ferroptosis

ESC Heart Failure, Volume 12, Issue 2, Page 1358-1373, April 2025.
Abstract Aim: Dapagliflozin (Dapa) is a novel hypoglycaemic agent with multiple cardiovascular protective effects, and it is widely used in treatment of heart failure patients, but whether it can improve obese phenotype of heart failure and its mechanism is still unclear.
Di Chen, Jiahao Shi, Yue Wu, Lizhu Miao, Zilin Wang, Yixuan Wang, Siwei Xu, Yu Lou   +7 more
wiley   +1 more source